Form 4: Pfizer CEO Albert Bourla Reports Acquisition of Phantom Stock Units

Pfizer's Chairman and CEO, Albert Bourla, reported the acquisition of phantom stock units through the company's Supplemental Savings Plan.

Summary

• On October 31, 2024, Albert Bourla, Chairman & CEO of Pfizer Inc., acquired 19 phantom stock units through the Pfizer Supplemental Savings Plan (SSP).
• Each unit represents one phantom share of Pfizer common stock.
• The price of the phantom stock units was $28.3.
• Following the transaction, Bourla directly owns 679,129 shares of Pfizer common stock.
• The phantom stock units are settled in cash following Bourla's separation from service and can be transferred into an alternative investment account at any time.

Sentiment

Score: 7

Explanation: The document is a neutral report of a standard executive compensation transaction. It doesn't contain any information that would significantly impact investor sentiment positively or negatively.

Positives

• The acquisition of phantom stock units aligns the CEO's interests with those of the shareholders.
• The Supplemental Savings Plan provides a mechanism for executives to accumulate wealth tied to the company's performance.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This filing is a routine disclosure of executive compensation and stock ownership, common in publicly traded companies. It provides transparency into the alignment of management's interests with shareholders.

Comparison to Industry Standards

• Executive compensation packages often include a mix of salary, stock options, restricted stock, and performance-based bonuses.
• Phantom stock units are a common tool used to incentivize executives without diluting existing shareholders' equity.
• Companies like Johnson & Johnson (JNJ) and Merck (MRK) also utilize similar compensation strategies to align executive interests with company performance.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders by aligning the CEO's interests with the company's performance.

Key Dates